Senate launches probe into high Ozempic and Wegovy prices in the US
U.S. Sen. Bernie Sanders sent letter on Wednesday to Novo Nordisk CEO Lars Fruergaard Jørgensen announcing that the Senate Committee on Health, Education, Labor, and Pensions, which Sanders chairs, has launched an investigation into the high prices the company charges for its blockbuster diabetes and weight loss dugs.